← Russell 3000 cross-section

INNV InnovAge Holding Corp.

Trailing twelve months to 2026-03-31 · as filed 2026-05-08, not restated
Healthcare

Scale

Market cap
$1.5bn
Revenue TTM
$949m
Net income TTM
$-12m
Free cash flow
$43m
Composite score
56.3
Sector rank
#1794

Valuation

P / E
EV / EBITDA
167.0
EV / sales
1.5
FCF yield
2.83%
Earnings yield vs 10-yr
-5.50pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-1.2%
EBITDA margin
0.9%
ROE
-5.1%
ROIC
-6.6%
Revenue growth
14.1%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We anticipate increased cost of care from our third-party service providers in an effort to offset their heightened expenses resulting, in part, from budget pressures due to the OBBBA, budget cuts to providers from state Medicaid programs, and possible increases in cost of medical and other supplies used in order to provide healthcare services. Partially as a result of increased competition and other market trends, there was an increase in the cost of care for the third quarter of fiscal year 2026 compared to the comparable period for fiscal year 2025, as discussed in "Results of Operations" below. …InnovAge Holding Corp., 10-Q, period ended 2026-03-31, filed 2026-05-08

Read the full passage →